Publikation

Interferon alpha-2a Plus Ribavirin 1,000/1,200 mg versus Interferon alpha-2a Plus Ribavirin 600 mg for Chronic Hepatitis C Infection in Patients on Opiate Maintenance Treatment: An Open-Label Randomized Multicenter Trial

M. Huber, R. Weber, R. Oppliger, P. Vernazza, P. Schmid, P. Schönbucher, B. Bertisch, D. Meili and E. L. Renner

Wissenschaftlicher Artikel/Review - 01.02.2005